Author

Laia Joval-Ramentol

Observed institution: Vall d'Hebron Institute of Oncology

ORCID: 0000-0002-2253-0980

Observed ORCID: 0000-0002-2253-0980

OpenAlex ID: A5093437752

Taxanes for the treatment of breast cancer during pregnancy: an international cohort study

2023 · Ana S Ferrigno Guajardo, Bryan F Vaca-Cartagena, et al. · JNCI Journal of the National Cancer Institute · 17

Abstract P2-01-16: Pharmacogenomic variants and risk of adverse events in breast cancer patients treated with Trastuzumab-deruxtecan: results from the PROCURE project

2025 · Rodrigo Sánchez-Bayona, Javier de Nicolás-Hernández, et al. · Clinical Cancer Research · 3

Abstract PS13-03: Safety of taxane chemotherapy for the treatment of breast cancer during pregnancy: an international cohort study

2024 · Ana Ferrigno Guajardo, Bryan Vaca-Cartagena, et al. · Cancer Research

Abstract PO4-09-01: Survival of patients harboring a germline ATM pathogenic/likely pathogenic variant and diagnosed with breast cancer: A case-control study

2024 · Mara Cruellas, Ariadna Roqué, et al. · Cancer Research

Abstract PO4-01-06: HER2-positive early breast cancer (EBC): treatment, toxicities and outcomes in a retrospective cohort of elderly patients (pts)

2024 · Alejandra Rezqallah, Diego Gómez-Puerto, et al. · Cancer Research

Works count: 5

Citation count: 20

H-index: 2

I10-index: 1